The Development Bank of Wales has taken an equity stake in Cardiff-based Llusern Scientific as part of a substantial six-figure funding round that is helping the University of South Wales spinout to commercialise its testing for Urinary Tract Infections (UTIs).
Read the full story on UK Tech News
The Lodestar DX analyser and testing system is registered with the European Patent Office (European Patent Application no: 22732302.9) and the US Patent and Trademark Office (no.18/558,490).